Reference : Radiothérapie vasculaire : un nouveau standard
Scientific journals : Article
Human health sciences : Oncology
http://hdl.handle.net/2268/72944
Radiothérapie vasculaire : un nouveau standard
English
[en] Endovascular radiation therapy : a new standard
Coucke, Philippe mailto [Centre Hospitalier Universitaire Vaudois (Lausanne) > Laboratoire de radiobiologie > radio-oncologie > >]
HU PHUOC DO [ > > ]
URBAN, Ph. [Centre Hospitalier Universitaire Vaudois (Lausanne) > cardiologie > > >]
PACHE, G. [Centre Hospitalier Universitaire Vaudois (Lausanne) > Institut de radiophysique appliquée > > >]
LATCHEM [Centre Hospitalier Universitaire Vaudois (Lausanne) > cardiologie > > >]
PICA, A. [Centre Hospitalier Universitaire Vaudois (Lausanne) > Laboratoire de radiobiologie > radio-oncologie > >]
EECKHOUT, E. [Centre Hospitalier Universitaire Vaudois (Lausanne) > cardiologie > > >]
2001
Médecine et Hygiène
Editions Médecine et Hygiène
59
2342
853-858
Yes (verified by ORBi)
International
0025-6749
[en] Radiotherapy ; Indication ; Human ; Technique ; Angioplasty ; Cardiovascular disease ; Stenosis ; Blood vessel ; Sténose ; Vaisseau sanguin
[fr] Radiothérapie ; Homme ; Indication ; Technique ; Angioplastie ; Appareil circulatoire pathologie
[fr] Le traitement des maladies cardiovasculalres, et plus spécifiquement la prise en charge des patients avec des sténoses vasculalres, qu'elles soient cardiaques ou périphériques, est en train d'être modifié de façon radicale. Avec l'Introduction des techniques d'angioplastie par vole transcutanée (PTCA) et la mise en place de « stents », on a certainement amélioré le devenir de ces malades. Toutefois, l'incidence de resténose après ces interventions endovasculaires reste élevée. Ce phénomène d'oblitération vasculaire après angloplastie ou stent s'explique en partie par des mécanismes de prolifération néointimale. On s'est donc logiquement tourné vers les radiations ionisantes comme alternative thérapeutique possible vu leur efficacité sur les processus de prolifération cellulaire, Autant pour les lésions de novo que les resténoses in-stent, on observe l'efficacité des radiations ionisantes. Les résultats des premiers essais randomisés ont été rendus publics et ceci va certainement changer les standards de prise en charge en cardiologie interventionnelle.
Researchers ; Professionals ; Students ; General public ; Others
http://hdl.handle.net/2268/72944
Bibliographie : 1 Gruentzig AR. Transluminal dilatation of coronary artery stenosis. Lancet 1978 ; 1 : 263. 2 Rupprecht HJ, Brennecke R, Bernhard G, et al. Analysis of risk factors for restenosis after PTCA. Cathet Cardiovasc Diagn 1990 ; 19 : 151-9. 3 Serruys PW, Foley DP, Kirkeide RL, King SB, III. Restenosis revisited : Insights provided by quantitative coronary angiography. Am Heart J 1993 ; 126 : 1243-67. 4 Weintraub WS, Boccuzzi SJ, Klein JL, et al. Lack of effect of lovastatin on restenosis after coronary angioplasty. N Engl J Med 1994 ; 331 : 1331-7. 5 Nobuyoshi M, Kimura T, Nosaka H, et al. Restenosis after successful percutaneous transluminal coronary angioplasty : Serial angiographic follow-up of 229 patients. J Am Coll Cardiol 1988 ; 12 : 616-23. 6 Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon expandable stent implantation and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994 ; 331 : 489-95. 7 Fischman DL, Leon MB, Baim DS, et al. Randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994 ; 331 : 496-501. 8 Erbel R, Haude M, Höpp HW, et al. for the Restenosis stent Study Group. Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. N Engl J Med 1998 ; 339 : 1672-8. 9 Schwartz RS. The vessel wall reaction in restenosis. Semin Intervent Cardiol 1997 ; 2 : 83-8. 10 Kantor G, Van Houtte P, Beauvois S, Roelandts M. Rôle de la radiothérapie dans les affections bénignes. Cancer/Radiother 1997 ; 1 : 407-16. 11 Waksman R. Intracoronary brachytherapy in the cath lab. Physics, dosimetry, technology and safety considerations. Herz 1998 ; 23 : 401-6. 12 Verin V, Popowski Y. Intrarterial beta irradiation to reduce restenosis after PTCA. Herz 1998 ; 23 : 347-55. 13 Urban P, Verin V, Popowski Y, Rutishauer W. Feasibility and safety of beta irradiation in human coronary arteries. Semin Intervention Cardiol 1997 ; 2 : 125-31. 14 Lee DP, Lo S, Foster KM, et al. Intra- coronary irradiation with a 32P source wire. Herz 1998 ; 23 : 362-5. 15 Weinberger J. Intracoronary radiation using radioisotope solution-filled balloons. Herz 1998 ; 23 : 366-72. 16 Friedman M, Byers SO. Effects of Iridium 192 radiation on thrombo-atherosclerotic plaque in the rabbit aorta. Arch Path 1965 ; 80 : 285-91. 17 Waksman R. Response to radiation therapy in animal restenosis models. Semin Intervention Cardiol 1997 ; 2 : 95-101. 18 Waksman R. Progress in clinical trials for coronary arterial restenosis using beta radiation sources. Cardiovasc Radiat Med 1999 ; 1 : 220-6. 19 Waksman R, Robinson KA, Crocker IR, et al. Intracoronary radiation decreases the second phase of intimal hyperplasia in repeat balloon angioplasty model of restenosis. Int J Radiat Oncol Biol Phys 1997 ; 39 : 475-8. 20 Rubin P, Williams J, Riggs PN, et al. Cellular and molecular mechanisms of radiation inhibition of restenosis. Part I : Role of the macrophage and platelet derived growth factor. Int J Radiat Oncol Biol Phys 1998 ; 40 : 929-41. 21 Fajardo LF. The nature of arterial restenosis after angioplasty. Int J Radiat Oncol Biol Phys 1998 ; 40 : 761-3. 22 Powers BE, Thames HD, Gillette EL. Long-term adverse effects of radiation inhibition of restenosis : Radiation injury of the aorta and branch arteries in a canine model. Int J Radiat Oncol Biol Phys 1999 ; 45 : 753-9. 23 Williams JP, Eagleton M, Hernady E, et al. Effectiveness of fractionated external beam radiation in the inhibition of vascular restenosis. Cardiovasc Radiat Med 1999 ; 1 : 257-64. 24 Razavi M, Rege S, Zeigler W, et al. Feasibility of external beam radiation for prevention of restenosis following balloon angioplasty. Int J Radiat Oncol Biol Phys 1999 ; 44 : 363-7. 25 Schäfer U, Micke O, Dorszewski A, et al. External beam irradiation inhibits neointima hyperplasia after injury-induced arterial smooth muscle cell proliferation. Int J Radiat Oncol Biol Phys 1998 ; 42 : 617-22. 26 Amols HI. Editorial comment on «long-term adverse effects of radiation inhibition of restenosis». Int J Radiat Oncol Biol Phys 1999 ; 45 : 551-2. 27 Condado JA, Waksman R, Gurdiel O, et al. Long-term angiographic and clinical outcome after percutaneous transluminal coronary angioplasty and intracoronary radiation therapy in humans. Circulation 1997 ; 96 : 727-32. 28 Teirstein P. Gamma versus beta radiation for the treatment of restenosis. Herz 1998 ; 23 : 335-6. 29 Teirstein P, Massullo V, Jani S, et al. Three-year clinical and angiographic follow-up after intracoronary radiation. Results of a randomized clinical trial. Circulation 2000 ; 101 : 360-5. 30 Lansky AJ, Popma JJ, Massullo V, et al. Quantitative angiographic analysis of stent restenosis in the Scripps coronary radiation to inhibit intimal proliferation post stenting (SCRIPPS) trial. Am J Cardiol 1999 ; 84 : 410-4. 31 Waksman R, White L, Chan RC, et al, for the Washington Radiation for In-Stent Restenosis Trial (WRIST) investigators. Intracoronary g-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. Circulation 2000 ; 101 : 2165-71. 32 Fischell RE, Fischell TA. Intra-arterial stent with the capability to inhibit intimal hyperplasia. US patent 5 059 166. October 22, 1991. 33 Fischell TA, Hehrlein C. The radiosiotope stent for the prevention of restenosis. Herz 1998 ; 23 : 373-9. 34 Carter AJ, Fischell TA. Current status of radioactive stents for the prevention of in-stent restenosis. Int J Radiat Oncol Biol Phys 1998 ; 41 : 127-33. 35 Serruys PW, Kay PI. I like the candy, I hate the wrapper. Circulation 2000 ; 101 : 3-7. 36 Albiero R, Adamian M, Kobayashi N, et al. Short- and intermediate-term results of 32P radioactive b-emitting stent implantation in patients with coronary artery disease. The Milan dose-response study. Circulation 2000 ; 101 : 18-26. 37 Luo Z, Sata M, Nguyen T, et al. Adenovirus-mediated delivery of Fas ligand inhibits intimal hyperplasia after balloon injury in immunologically primed animals. Circulation 1999 ; 99 : 1776-9. 38 Dollery CM, Humpries SE, McClelland A, et al. Expression of tissue inhibitor of matrix metalloproteinases 1 by use of an adenoviral vector inhibits smooth muscle cell migration and reduces neointimal hyperplasia in the rat model of vascular balloon injury. Circulation 1999 ; 99 : 3199-205. 39 Hart CE, Kraiss LW, Vergel S, et al. PDGFb receptor blockade inhibits intimal hyperplasia in the baboon. Circulation 1999 ; 99 : 564-9. 40 Bilder G, Wentz T, Leadley R, et al. Restenosis following angioplasty in the swine coronary artery is inhibited by an orally active PDGFb-receptor tyrosine kinase inhibitor RPR101511A. Circulation 1999 ; 99 : 3292-9. 41 King III, SB. Radiation for restenosis. Watchfull waiting. Circulation 1999 ; 99 : 192-4. 42 Mehran R, Dangas G, Abizaid AS, et al. Angiographic patterns of in-stent restenosis. Circulation 1999 ; 100 : 1872-8.

There is no file associated with this reference.

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.